Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

130.96
+2.582.01%
Post-market: 130.960.00000.00%19:17 EST
Volume:990.96K
Turnover:129.24M
Market Cap:13.14B
PE:28.04
High:131.38
Open:129.09
Low:128.03
Close:128.38
52wk High:160.18
52wk Low:84.23
Shares:100.36M
Float Shares:98.00M
Volume Ratio:0.82
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.67
EPS(LYR):4.67
ROE:16.38%
ROA:9.53%
PB:4.04
PE(LYR):28.04

Loading ...

Feb 11, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2026

Major Issues Report

Form 8-K - Current report
Jan 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 24, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jul 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Major Issues Report

Form 8-K - Current report
May 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities